Single-nucleotide polymorphisms in the UDP-glucuronosyltransferase 1A-3' untranslated region are associated with atazanavir-induced nephrolithiasis in patients with HIV-1 infection: a pharmacogenetic study

Ritonavir-Boosted Darunavir Is Rarely Associated with Nephrolithiasis Compared with Ritonavir-Boosted Atazanavir in HIV-Infected Patients

(2013) Takeshi Nishijima et al.   PLoS One

A Population Pharmacokinetic-Pharmacogenetic Analysis of Atazanavir

(2012) Deidre A. Kile et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

High Incidence of Renal Stones Among HIV-Infected Patients on Ritonavir-Boosted Atazanavir Than in Those Receiving Other Protease Inhibitor-Containing Antiretroviral Therapy

(2012) Y. Hamada et al.   CLINICAL INFECTIOUS DISEASES

Kidney Stone Formation is Positively Associated with Conventional Risk Factors for Coronary Heart Disease in Japanese Men

(2012) Ryosuke Ando et al.   JOURNAL OF UROLOGY

Role of Drug Efflux and Uptake Transporters in Atazanavir Intestinal Permeability and Drug-Drug Interactions

(2012) Olena Kis et al.   PHARMACEUTICAL RESEARCH

Kidney stones and kidney function loss: a cohort study

(2012) R. T. Alexander et al.   BMJ-British Medical Journal

Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir

(2011) Neesha Rockwood et al.   AIDS

Genetic Factors Influencing Severe Atazanavir‐Associated Hyperbilirubinemia in a Population with Low UDP‐Glucuronosyltransferase 1A1*28 Allele Frequency

(2010) Wan Beom Park et al.   CLINICAL INFECTIOUS DISEASES

Atazanavir Metabolism According to CYP3A5 Status: An In Vitro-In Vivo Assessment

(2010) M. F. Wempe et al.   DRUG METABOLISM AND DISPOSITION

HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms

(2010) Ruben C. Hartkoorn et al.   Pharmacogenetics and Genomics

Pharmacogenetics of antiretrovirals

(2009) Valerio Tozzi   ANTIVIRAL RESEARCH

Kidney Stones and the Risk for Chronic Kidney Disease

(2009) A. D. Rule et al.   Clinical Journal of the American Society of Nephrology

Association of a Single‐Nucleotide Polymorphism in the Pregnane X Receptor (PXR63396C→T) with Reduced Concentrations of Unboosted Atazanavir

(2008) Marco Siccardi et al.   CLINICAL INFECTIOUS DISEASES